Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 3:11:100132.
doi: 10.1016/j.xjmad.2025.100132. eCollection 2025 Sep.

Effect of depression treatment on subjective sleep components among primary care patients: Data from the eIMPACT trial

Affiliations

Effect of depression treatment on subjective sleep components among primary care patients: Data from the eIMPACT trial

Matthew D Schuiling et al. J Mood Anxiety Disord. .

Abstract

Objective: Sleep disturbance is a multifaceted symptom of depression that disproportionately impacts marginalized groups. Depression treatment improves sleep disturbance in some individuals; however, the components of sleep disturbance improved remain unidentified. This secondary analysis of the eIMPACT randomized controlled trial examines effects of depression treatment on subjective sleep disturbance components.

Methods: 216 primary care patients with depression from a safety net healthcare system were randomized to 12-months of modernized collaborative care (internet cognitive-behavioral therapy [CBT], telephonic CBT, and/or antidepressants; n = 107) or usual primary care for depression (primary care providers supported by embedded behavioral health clinicians and psychiatrists; n = 109). Subjective sleep disturbance components were assessed by the Pittsburgh Sleep Quality Index (PSQI).

Results: Mixed-effect models examined intervention effects on changes in subjective sleep disturbance components. The intervention improved PSQI global scores, sleep onset latency, subjective sleep quality, and daytime dysfunction across 24-months, and these effects diminished after treatment termination. At post-treatment, intervention participants had greater improvements in PSQI global scores (p < 0.001, d=-0.62), sleep onset latency (p < 0.01, d=-0.43), daytime dysfunction (p < 0.01, d=-0.35), and sleep disturbances (p = 0.01, d=-0.26) compared to usual care, but no differences in subjective sleep quality, total sleep time, sleep efficiency, or sleep medication use. Intervention effects were not moderated by race, education, or income. Pre- to post-treatment improvements in depressive symptoms were associated with improvements in some sleep disturbance components.

Conclusions: Depression treatment improves some, not all, subjective sleep disturbance components, with benefits diminishing after termination. Adjunctive interventions are likely needed to address the lingering components of sleep disturbance.

Clinicaltrialsgov idenifier: NCT02458690.

Keywords: collaborative care; depression; health disparities; internet interventions; randomized controlled trial; sleep disturbance.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Jesse C. Stewart reports financial support was provided by National Heart, Lung, and Blood Institute, R01 HL122245. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Effect of the eIMPACT intervention, versus usual primary care for depression, on subjective sleep components across 24 months. Outcomes were assessed at pre-treatment (baseline), mid-treatment (6-months), post-treatment (12-months), and follow-up (24-months). The graphs were created based on quadratic mixed-effects models for all outcomes except for total sleep time, sleep efficiency, and sleep medication use score. For these three outcomes, linear mixed effects models were used. All models were adjusted for baseline imbalance in education, income, and sleep medication use. PSQI = Pittsburgh Sleep Quality Index; n.s. = not significant. N = 216.

References

    1. Brody D.J., Pratt L.A., Hughes J.P., Prevalence of depression among adults aged 20 and over: United States, 2013-2016, 2018. - PubMed
    1. Greenberg P.E., Fournier A.A., Sisitsky T., Simes M., Berman R., Koenigsberg S.H., Kessler R.C. The economic burden of adults with major depressive disorder in the United States (2010 and 2018) PharmacoEconomics. 2021;39(6):653–665. doi: 10.1007/s40273-021-01019-4. - DOI - PMC - PubMed
    1. Hardeveld F., Spijker J., De Graaf R., Nolen W.A., Beekman A.T. Prevalence and predictors of recurrence of major depressive disorder in the adult population. Acta Psychiatr Scand. 2010;122(3):184–191. doi: 10.1111/j.1600-0447.2009.01519.x. - DOI - PubMed
    1. Lépine J.P., Briley M. The increasing burden of depression. Neuropsychiatr Dis Treat. 2011;7(1):3–7. doi: 10.2147/ndt.S19617. - DOI - PMC - PubMed
    1. Whooley M.A., Kiefe C.I., Chesney M.A., Markovitz J.H., Matthews K., Hulley S.B. Depressive symptoms, unemployment, and loss of income: the CARDIA study. Arch Intern Med. 2002;162(22):2614–2620. doi: 10.1001/archinte.162.22.2614. - DOI - PubMed

Associated data

LinkOut - more resources